An update on pediatric cutaneous drug eruptions

被引:11
|
作者
Song, James E. [1 ]
Sidbury, Robert [2 ]
机构
[1] Univ Calif Irvine, Dept Dermatol, Irvine Sch Med, Irvine, CA 92697 USA
[2] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Pediat,Div Dermatol, Seattle, WA 98105 USA
关键词
STEVENS-JOHNSON-SYNDROME; GENERALIZED EXANTHEMATOUS PUSTULOSIS; TOXIC EPIDERMAL NECROLYSIS; INDUCED ACRAL ERYTHEMA; HIGH-DOSE METHOTREXATE; INDUCED PSORIASIS; RISK-FACTORS; CHILDREN; ACROCYANOSIS; MULTIFORME;
D O I
10.1016/j.clindermatol.2014.02.005
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
One of the early lessons learned in dermatology training is "any drug, any rash." This maxim quickly summarizes the vast array of cutaneous reactions that can be seen in response to systemic medications. We have reviewed common and unusual drug eruptions in pediatric patients that span the morphologic spectrum. These reactions can have an equally broad range of severity, from harmless to lethal, and by the end of this paper the reader will be better equipped to sort one from the other. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:516 / 523
页数:8
相关论文
共 50 条
  • [41] Severe adverse cutaneous drug eruptions: epidemiological and clinical features
    Zaraa, Ines
    Jones, Meriem
    Trojjet, Sondes
    Rouhou, Rym Cheikh
    El Euch, Dalenda
    Mokni, Mourad
    Ben Osman, Amel
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (07) : 877 - 880
  • [42] Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions
    Cheraghlou, Shayan
    Levy, Lauren L.
    CLINICS IN DERMATOLOGY, 2020, 38 (06) : 679 - 692
  • [43] Cutaneous Drug Reactions in the Pediatric Population
    Noguera-Morel, Lucero
    Hernandez-Martin, Angela
    Torrelo, Antonio
    PEDIATRIC CLINICS OF NORTH AMERICA, 2014, 61 (02) : 403 - +
  • [44] A temporal cluster of cutaneous drug eruptions developing after initiation of hydroxychloroquine
    Jadeja, S.
    Temiz, L. A.
    Dewan, A. K.
    Parker, E. R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (03) : 252 - 254
  • [45] Methods for Identifying Culprit Drugs in Cutaneous Drug Eruptions: A Scoping Review
    Bose, Reetesh
    Ogbalidet, Selam
    Boshra, Mina
    Finstad, Alexandra
    Marzario, Barbara
    Huang, Christina
    Fahim, Simone
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (02) : 162 - 168
  • [46] Recognizing cutaneous drug eruptions - Reaction patterns provide clues to causes
    Daoud, MS
    Schanbacher, CE
    Dicken, CH
    POSTGRADUATE MEDICINE, 1998, 104 (01) : 101 - +
  • [47] Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions - Implications for management
    Crowson, AN
    Brown, TJ
    Magro, CM
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (06) : 407 - 428
  • [48] Adverse cutaneous drug eruptions and HIV: a clinician's global perspective
    Todd, Gail
    DERMATOLOGIC CLINICS, 2006, 24 (04) : 459 - +
  • [49] Cutaneous drug eruptions in the dog and cat: Clinical cases and literature review
    Kohn, B
    Roosje, P
    KLEINTIERPRAXIS, 1997, 42 (01): : 31 - &
  • [50] Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions
    Yawalkar, N
    Egli, F
    Hari, Y
    Nievergelt, H
    Braathen, LR
    Pichler, WJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2000, 30 (06): : 847 - 855